Fertility

Prevalence

737.7 / 100K

11 drugs in development·7 companies·3 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
Alinity® family	ABBOTT LABORATORIES (ABT)
artguide	PREDICTIVE TECHNOLOGY GROUP, INC. (PRED)
fertilitydx	PREDICTIVE TECHNOLOGY GROUP, INC. (PRED)
Ganirelix acetate injection (Orgalutran)	Organon & Co. (OGN)

Phase 2(2)

Drug	Company
Estradiol	ENANTA PHARMACEUTICALS INC (ENTA)
MVT-602	Myovant Sciences Ltd. (MYOV)

Preclinical(1)

Drug	Company
AZD5904	CDT Equity Inc. (CDT)

Unknown(1)

Drug	Company
Alova	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

N/A(3)

Drug	Company
Clomiphene Citrate.	ENANTA PHARMACEUTICALS INC (ENTA)
Guaifenesin	ENANTA PHARMACEUTICALS INC (ENTA)
OvaStem™	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

BioSniper tracks 11 drugs in development for Fertility across 7 companies.

There are 3 clinical trials targeting Fertility tracked by BioSniper.

The estimated prevalence of Fertility is approximately 737.7 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.